RLMD Live signals | Maximize Profits with Getagraph.com

BUY 103260 min ago

@ $5.51

Issued: 14 Feb 2024 @ 15:13

Return: -32.85%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: 2.99 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders...

Stats
Today's Volume	85 395.00
Average Volume	215 238
Market Cap	111.64M
EPS	$0 ( 2024-03-19 )
Next earnings date	( $-0.900 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.130
ATR14	$0.0170 (0.46%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-31	Traversa Sergio	Buy	27 460	Common Stock
2024-01-30	Traversa Sergio	Buy	40 999	Common Stock
2024-01-29	Traversa Sergio	Buy	31 541	Common Stock
2024-01-31	Shenouda Maged	Buy	6 875	Common Stock
2024-01-30	Shenouda Maged	Buy	15 000	Common Stock

INSIDER POWER
66.72
Last 97 transactions
Buy: 7 635 369 \| Sell: 1 906 109

Volume Correlation

Long: -0.04 (neutral)

Short: -0.55 (weak negative)

Signal:(41.213) Neutral

Relmada Therapeutics Inc Correlation

10 Most Positive Correlations
TCRT	0.953
WISA	0.929
TTCF	0.925
MDVL	0.919
KVSB	0.918
VSTA	0.915
VIRX	0.914
QTEK	0.914
FNCH	0.913
AVO	0.912

10 Most Negative Correlations
BNIXU	-0.92
STAY	-0.904
SLGN	-0.904
CCRC	-0.903
WEN	-0.903
MGI	-0.903
IBEX	-0.9
IMMR	-0.899
ISIG	-0.898
MNKD	-0.88

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Relmada Therapeutics Inc Correlation - Currency/Commodity

0.38
( neutral )

-0.11
( neutral )

0.00
( neutral )

0.28
( neutral )

0.00
( neutral )

-0.48
( neutral )

Relmada Therapeutics Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-3.28

FY	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-3.28

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-5.30

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-8.06

Financial Reports:

No articles found.

Relmada Therapeutics Inc

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.